Kim YZ. Brain Tumor Res Treat. 2014 Apr;2(1):7-21. http://dx.doi.org/10.14791/btrt.2014.2.1.7

Jang JH, et al. J Korean Med Sci. 2011 Jan;26(1):100-107. http://dx.doi.org/10.3346/jkms.2011.26.1.100

Kim YZ, et al. Brain Tumor Res Treat. 2022 Apr;10(2):83-93. https://doi.org/10.14791/btrt.2022.0001

Object The aim of this study was to evaluate the role of certain cell-cycle regulatory proteins in the recurrence of atypical meningiomas. These proteins were analyzed with immunohistochemical staining to identify predisposing factors for the recurrence of atypical meningiomas. Methods The authors retrospectively reviewed the medical records of patients with atypical meningiomas diagnosed in the period from January 2000 to June 2012 at the Department of Neurosurgery at Samsung Changwon Hospital and Dong-A University Medical Center. Clinical data included patient sex and age at the time of surgery, presenting symptoms at diagnosis, location and size of tumor, extent of surgery, use of postoperative radiotherapy, duration of follow-up, and recurrence. Immunohistochemical staining for cell-cycle regulatory proteins (p16, p15, p21, p27, cyclin-dependent kinase [CDK] 4 and 6, phosphorylated retinoblastoma [pRB] protein, and cyclin D1) and proliferative markers (MIB-1 antigen, mitosis, and p53) was performed on...

Kim DC, et al. J Korean Neurosurg Soc. 2016 Jan;59(1):26-36. http://dx.doi.org/10.3340/jkns.2016.59.1.26